logo
10-Month-Old Baby Girl In Sweden Develops "Micropenis" After Lying On Father's Bare Chest

10-Month-Old Baby Girl In Sweden Develops "Micropenis" After Lying On Father's Bare Chest

NDTV2 days ago
In a bizarre and concerning case, a 10-month-old baby girl in Sweden developed a "micropenis" after prolonged skin contact with her father, who had applied testosterone gel. According to the New York Post, the unusual medical incident is drawing widespread attention both online and within the healthcare community. The case highlights the potential risks of accidental hormone exposure through skin-to-skin contact. A Swedish doctor has also raised an alarm, revealing that she has encountered at least half a dozen similar cases involving children.
According to the Post, the girl's condition, though sensationalised, isn't a true "micropenis" - a term reserved for underdeveloped male genitalia. In the girl's case, she developed masculinised genital changes after she was repeatedly placed on her father's bare chest - the same area where he had applied testosterone gel.
This medication is commonly prescribed to men with hypogonadism, a condition in which the body doesn't produce enough sex hormones. This condition can affect men of any age, but studies suggest that roughly 40% of those over 45 and half of men in their 80s have clinically low testosterone. This medicine can lead to a range of symptoms, including low sex drive, erectile dysfunction, fatigue, mood swings and muscle loss - issues that testosterone replacement therapy (TRT) can help treat.
Unaware of these risks, the father's regular skin-to-skin contact with the baby girl inadvertently exposed his daughter to high levels of testosterone, triggering the dramatic changes in her body.
As soon as her parents noticed her clitoris had begun to elongate, resembling a small penis, they rushed to the hospital. Blood tests quickly identified the source. Fortunately, her genitals began to shrink once her father stopped using the gel and the accidental exposure ceased.
"I don't think people always understand how potent these treatments are," said Professor Jovanna Dahlgren, a pediatric endocrinologist at Sahlgrenska University Hospital, per the Post.
"The parents become completely desperate when they understand what has happened," she added.
The professor also noted that this is not the first time this has happened. She said that in one case, a 10-year-old boy developed breasts after coming into contact with estrogen cream his mother had been using.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Male contraceptive YCT-529 a breakthrough? Birth control pill that temporarily halts sperm without hormones clears trial
Male contraceptive YCT-529 a breakthrough? Birth control pill that temporarily halts sperm without hormones clears trial

Mint

time10 hours ago

  • Mint

Male contraceptive YCT-529 a breakthrough? Birth control pill that temporarily halts sperm without hormones clears trial

In a new development, men may soon be able to equitably share the responsibility of avoiding pregnancy along with their partners as YCT-529, a birth control experimental pill has passed its initial human safety test, making another way for contraception. It will reportedly cease sperms temporarily without hinderance to hormones. Unlike conventional hormonal birth control pills, the innovative pill developed by YourChoice Therapeutics temporarily halts sperm production while leaving testosterone levels unchanged, New York Post reported. It functions by inhibiting a protein named retinoic acid receptor alpha, which is essential in the sperm creation process. Initial studies indicate that its effects are completely reversible. In tests involving male mice, YCT-529 significantly decreased sperm production, leading to reversible infertility after only four weeks of treatment. When these treated males bred with females, the drug demonstrated a 99% success rate in preventing pregnancy. Comparable outcomes were observed in male nonhuman primates, with sperm counts declining within two weeks of beginning the treatment. Importantly, fertility was fully restored in both species once the drug was discontinued. Mice recovered within six weeks, while primates regained fertility between 10 and 15 weeks. No side effects were noted in either group throughout the studies, the report added. The initial human trial of the medication included 16 healthy males aged 32 to 59, all of whom had previously had vasectomies, a surgical operation that severs and blocks the tubes transporting sperm from the testicles to prevent conception. This additional safety measure was required because no nonhormonal male contraceptive had ever been evaluated in humans before. Scientists wanted to eliminate any chance of permanently impacting fertility, in case participants wished to have children later, Nadja Mannowetz, co-founder and chief science officer of YourChoice Therapeutics, informed Scientific American. She clarified the objective was not to assess effectiveness but to determine if the drug was tolerated well and to observe how it accumulated in the body. Researchers tested multiple doses and found no concerning side effects. There were no changes in heart rate, hormone levels, inflammation, sexual function, or mood. This finding is important because hormonal contraceptives have previously been linked to side effects like mood swings, decreased libido, weight gain, and acne. Mannowetz pointed out that across all doses, the drug demonstrated good and rapid bioavailability, which means it remained active in the body without breaking down too quickly, the report mentioned.

ICMR study found Covid vaccination didn't raise risk of unexplained sudden deaths among young adults: J P Nadda
ICMR study found Covid vaccination didn't raise risk of unexplained sudden deaths among young adults: J P Nadda

Economic Times

timea day ago

  • Economic Times

ICMR study found Covid vaccination didn't raise risk of unexplained sudden deaths among young adults: J P Nadda

An ICMR study has found that Covid vaccination did not increase the risk of unexplained sudden deaths among young adults in India, Union Health Minister J P Nadda told Lok Sabha on Covid hospitalization, family history of sudden death and certain lifestyle behaviours increased the likelihood of unexplained sudden to a question, Nadda said the Indian Council of Medical Research (ICMR) has informed that it and the National Centre for Disease Control (NCDC) explored two approaches to investigate the causes of sudden first approach was a retrospective case-control study to determine the risk factors associated with sudden death and the second approach of the study was to prospectively investigate sudden deaths in young adults using a virtual autopsy ICMR-National Institute of Epidemiology (NIE) conducted a study titled "Factors associated with unexplained sudden deaths among adults aged 18-45 years in India - A multicentric matched case-control study" at 47 tertiary care hospitals located across 19 states and Union territories during May-August 2023. Cases were apparently healthy individuals without any known co-morbidity, who suddenly (less than 24 hours of hospitalization or seen apparently healthy 24 hours before death) died of unexplained causes during October 1, 2021-March 31, 2023, Nadda controls were included per case matched for age, gender and was collected regarding data on COVID-19 vaccination/infection, post-Covid conditions, family history of sudden death, smoking, recreational drug use, alcohol frequency, binge drinking and vigorous-intensity physical activity two days before death among the cases or interviewed controls, he said.A total of 729 sudden death cases and 2916 controls were included in the was observed that receiving two doses of Covid vaccine significantly reduced the odds of unexplained sudden death, Nadda COVID-19 hospitalization, family history of sudden death, binge drinking 48 hours before death/interview, use of recreational drug/substance and performing vigorous-intensity physical activity 48 hours before death/interview increased the odds of sudden death."Hence, the study observed that COVID-19 vaccination did not increase the risk of unexplained sudden death among young adults in India. Past COVID-19 hospitalization, family history of sudden death and certain lifestyle behaviours increased the likelihood of unexplained sudden death," he second study, titled "Establishing the cause in sudden unexplained deaths in young" conducted by the All India Institute of Medical Sciences (AIIMS), Delhi with funding and in collaboration with ICMR, is a prospective work aimed at determining the common causes of sudden deaths in young analysis of data from the study indicates that heart attacks, or myocardial infarction (MI), continue to be the leading cause of sudden death in this age group. Importantly, no major changes in the pattern of causes have been observed when compared with previous years before the Covid these two studies offer a more comprehensive understanding of sudden unexplained deaths in young adults in India, Nadda said. It has also been revealed that Covid vaccination does not appear to increase the risk, whereas, the role of underlying health issues, genetic predisposition and risky lifestyle choices does play a role in unexplained sudden deaths, he said.

Covid-19 jabs not linked to sudden deaths, says Nadda in Lok Sabha
Covid-19 jabs not linked to sudden deaths, says Nadda in Lok Sabha

United News of India

timea day ago

  • United News of India

Covid-19 jabs not linked to sudden deaths, says Nadda in Lok Sabha

New Delhi, July 25 (UNI) Union Health Minister JP Nadda today informed Lok Sabha that Covid-19 vaccination does not increase the risk of unexplained sudden deaths, and pointed instead to underlying health issues, genetic predisposition, and lifestyle factors as key contributors. Responding during the ongoing Monsoon Session, Nadda cited findings from multiple studies conducted by the Indian Council of Medical Research (ICMR), the National Centre for Disease Control (NCDC), and the All India Institute of Medical Sciences (AIIMS), Delhi. The studies, he said, had found no evidence linking Covid-19 vaccines to increased mortality among young adults. 'Covid-19 vaccination did not appear to elevate the risk of sudden death,' Nadda stated, adding that factors such as past Covid-19 hospitalisation, family history of sudden death, recreational drug use, binge drinking, and intense physical activity shortly before death were more strongly associated with such cases. Referring to a retrospective case-control study by ICMR-National Institute of Epidemiology (NIE), the Minister said the research covered 47 tertiary care hospitals across 19 states and Union Territories between May and August 2023. It examined 729 sudden death cases involving adults aged 18-45 with no known comorbidities, alongside 2,916 matched controls. The study analysed data related to Covid-19 vaccination status, previous infection, post-Covid conditions, familial health history, and behavioural factors. Notably, individuals who had received two doses of the vaccine showed a significantly lower risk of unexplained sudden death. A second, prospective study led by AIIMS Delhi, in collaboration with ICMR, sought to establish definitive causes of sudden deaths among young adults through virtual autopsy techniques. Preliminary findings reaffirmed that heart attacks, or myocardial infarction (MI), remain the leading cause of sudden deaths in this demographic. Crucially, the pattern of causes has not changed significantly when compared to pre-pandemic years. 'These studies collectively offer a deeper insight into the phenomenon of sudden unexplained deaths,' Nadda said. 'Vaccination is not a contributing factor; rather, it may be protective. The emphasis must remain on identifying and addressing underlying health risks and lifestyle practices.' Meanwhile, Minister of State for Health Prataprao Jadhav informed the House that 164 Covid-related deaths were reported by States and Union Territories between April and July this year. Most of the deceased had existing comorbidities. 'Covid-19 cases saw a modest uptick from late May, but declined significantly by mid-June,' Jadhav said in a written reply. As of July 22, a total of 164 deaths had been recorded during the summer wave, he added. UNI AJ RN

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store